A detailed history of Israel Englander (Millennium Management LLC) transactions in Boston Scientific Corp stock. As of the latest transaction made, Millennium Management LLC holds 885,100 shares of BSX stock, worth $66.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
885,100
Previous 1,796,800 50.74%
Holding current value
$66.1 Million
Previous $104 Million 41.64%
% of portfolio
0.03%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $122 Million - $145 Million
2,111,388 Added 28.66%
9,479,667 $649 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $139 Million - $165 Million
-2,851,797 Reduced 27.9%
7,368,279 $426 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $6.72 Million - $7.38 Million
135,093 Added 1.34%
10,220,076 $553 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $40.1 Million - $44.5 Million
890,070 Added 9.68%
10,084,983 $480 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $38.2 Million - $45.6 Million
965,210 Added 11.73%
9,194,913 $425 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $23.6 Million - $70.4 Million
-642,184 Reduced 7.24%
8,229,703 $319 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $176 Million - $236 Million
5,002,334 Added 129.27%
8,871,887 $331 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $78.3 Million - $86.3 Million
1,913,336 Added 97.81%
3,869,553 $171 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $53.1 Million - $62.6 Million
-1,395,931 Reduced 41.64%
1,956,217 $83.1 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $99.5 Million - $111 Million
2,414,437 Added 257.48%
3,352,148 $145 Million
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $12.4 Million - $14.2 Million
321,756 Added 52.24%
937,711 $40.1 Million
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $75.1 Million - $84.5 Million
-2,130,650 Reduced 77.57%
615,955 $23.8 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $36 Million - $45.6 Million
1,085,946 Added 65.39%
2,746,605 $98.7 Million
Q3 2020

Nov 16, 2020

BUY
$34.44 - $42.23 $55.3 Million - $67.8 Million
1,604,387 Added 2851.13%
1,660,659 $63.5 Million
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $86.8 Million - $112 Million
-2,876,279 Reduced 98.08%
56,272 $1.98 Million
Q1 2020

May 14, 2020

SELL
$25.83 - $45.71 $34.2 Million - $60.5 Million
-1,322,544 Reduced 31.08%
2,932,551 $95.7 Million
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $56.8 Million - $68 Million
1,499,587 Added 54.42%
4,255,095 $192 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $73.6 Million - $79.3 Million
-1,825,154 Reduced 39.84%
2,755,508 $112 Million
Q2 2019

Aug 15, 2019

BUY
$34.91 - $42.98 $155 Million - $190 Million
4,428,247 Added 2905.39%
4,580,662 $197 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $158 Million - $194 Million
-4,516,979 Reduced 96.74%
152,415 $47.2 Million
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $706,182 - $874,413
-21,458 Reduced 0.46%
4,669,394 $179 Million
Q4 2018

Feb 14, 2019

SELL
$31.73 - $39.04 $59.4 Million - $73.1 Million
-1,872,742 Reduced 28.53%
4,690,852 $166 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $25.6 Million - $30.1 Million
-780,380 Reduced 10.63%
6,563,594 $253 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $117 Million - $149 Million
-4,343,668 Reduced 37.16%
7,343,974 $240 Million
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $222 Million - $252 Million
8,814,457 Added 306.78%
11,687,642 $319 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $42 Million - $50.5 Million
1,694,949 Added 143.85%
2,873,185 $71.2 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $30.9 Million - $34.4 Million
1,178,236
1,178,236 $34.4 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $107B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.